OKYO Pharma Limited (LSE: OKYO) (“OKYO” or the “Company”), the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases
OKYO PHARMA LIMITED (OKYO.L) Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board
OKYO , the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce
Stock Market Watch: QFI, EUA, OKYO, TILS, SYME, PET, ZIOC & NQMI
Stocks that may or may not make the grade in the papers
OKYO PHARMA LIMITED (OKYO.L) CLNs to raise £1.4m, intends to list: NASDAQ
Issue of additional convertible loan notes to raise £1,437,104 and intention to seek dual listing on NASDAQ
Stock Market Watch: SYME, PIRES, 7DIG, BID & OKYO
What may or may not be in the papers
Share Talk Bulletin Board Heroes, Monday 17th August 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk, Sunday Brunch Bulletin Board Heroes, 9th August 2020.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Weekly Stock Market News, 9th August 2020
A busy week at Share Talk, on Tuesday 11th August at 6 pm Share Talk are proud to presents an Investor Webinar and Q & A with Condor Gold PLC.
OKYO PHARMA LIMITED (OKYO.L) Dr James Khodabakhsh MD named Chairman of the SAB
Dr James Khodabakhsh MD named Chairman of the Scientific Advisory Board at OKYO Pharma Ltd
Share Talk Bulletin Board Heroes, Monday 3rd August 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Weekly Stock Market News, 2nd August 2020
On Tuesday 11th August at 6pm Share Talk is proud to presents an Investor Webinar and Q & A with Condor Gold PLC. Condor Gold (CNR), is developing the fully
OKYO Pharma LTD (OKYO.L) Issue of convertible loan notes to raise £3,500,000
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS